Drug Trial Radar · NCT06620757
Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
234
Planned (sponsor's estimate)
Start
Oct 10, 2024
Primary completion
Oct 10, 2027
Study completion Oct 20, 2027
Sponsor
- Lead sponsor
- Fundación EPICAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 1, 2024
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Brief Summary: A prospective, multicenter, single-arm, non-randomized study including consecutive patients with nonvalvular AF(Atrial Fibrillation), with a CHA2DS2-VASc score ≥2 (men) or ≥3 (women), and contraindication for long-term anticoagulant treatment, with successful LAAC (Left Atrial Appendage Closure)procedure with the LAmbre device, who at discharge are eligible for short-term (3-months-only) SAPT. We want to assess if a short-term single antiplatelet therapeutic regime of Acetylsalicylic acid (ASA) 100 mg (or clopidogrel 75 mg if ASA contraindication), once daily, for 3 months is safe and effective at 12 months follow-up.
Conditions
- Atrial Fibrillation
Interventions
Single antiplatelet therapy (SAPT)Drug
Observational study of effectiveness and safety of SAPT (either with acetyl-salycilic acid or clopidogrel) after LAAO with Lambre device in patients with high risk of bleeding
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of strokeTime frame: 12 month
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Hospital Universitario A Coruña
A Coruña, Spain · Recruiting
Hospital Clínico San Carlos
Aravaca, Spain · Recruiting
Hospital Del Mar
Barcelona, Spain · Recruiting
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain · Recruiting
Hospital Universitari Vall D'Hebron
Barcelona, Spain · Recruiting
Hospital Clinic de Barcelona
Barcelona, Spain · Recruiting
Hospital Universitario Reina Sofía de Córdoba
Córdoba, Spain · Recruiting
Hospital Universitario La Paz
Fuencarral-El Pardo, Spain · Recruiting
Hospital Universitario de Cabueñes
Gijón, Spain · Recruiting
Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Spain · Recruiting
Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria, Spain · Recruiting
Hospital Universitario de Leon
León, Spain · Recruiting
Hospital Universitari Arnau de Vilanova
Lleida, Spain · Recruiting
Hospital Central de La Defensa Gómez Ulla
Madrid, Spain · Recruiting
Hospital Universitario Puerta De Hierro
Majadahonda, Spain · Recruiting
Hospital Regional Universitario de Málaga
Málaga, Spain · Recruiting
Hospital de Manises
Manises, Spain · Recruiting
Hospital Universitario Son Espases
Palma de Mallorca, Spain · Recruiting
Hospital Clínico Universitario de Salamanca
Salamanca, Spain · Recruiting
Hospital Universitario Virgen del Rocío
Seville, Spain · Recruiting
Hospital Universitario de Tarragona Juan XXIII
Tarragona, Spain · Recruiting
Hospital Universitario y Politécnico La Fe
Valencia, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.